ÑÇÖÞÌìÌÃ

Dr. Joshua Dubland is a laboratory scientist and clinical assistant professor in the Department of Pathology and Laboratory Medicine at BC Children's Hospital, ÑÇÖÞÌìÌÃ. Dr. Dubland completed his BSc in chemistry at Simon Fraser University, followed by an MSc in organic chemistry at the University of Toronto. He was then a research associate in the pharmaceutical industry for 4 years, working at both BRI Biopharmaceutical Research Inc. and QLT Inc. Work in the pharmaceutical industry focused on bioanalytical mass spectrometry development, validation, and data acquisition to support clinical and preclinical drug trials. Following this, Dr. Dubland completed his PhD in Experimental Medicine at ÑÇÖÞÌìÌà where his research focused on cellular mechanisms of lipid accumulation and removal in atherosclerosis. Dr. Dubland is currently located in the Newborn Screening and Biochemical Genetics Laboratory at BC Children's Hospital where his current research interests focus on the development of novel mass spectrometry-based assays for clinical diagnosis of inborn errors of metabolism. Additional research interests include applications of mass spectrometry and other next generation analytical technologies for biomarker and drug target discovery. Investigation of inherited lipid metabolism disorders, lysosomal storage disorders, and environmental stress factors associated with lifetime cardiovascular disease risk are of particular interest.